MORETTI, Rita
 Distribuzione geografica
Continente #
NA - Nord America 23.437
EU - Europa 21.713
AS - Asia 10.904
SA - Sud America 1.678
AF - Africa 337
OC - Oceania 84
Continente sconosciuto - Info sul continente non disponibili 19
Totale 58.172
Nazione #
US - Stati Uniti d'America 23.044
IT - Italia 10.094
SG - Singapore 3.904
PL - Polonia 3.792
CN - Cina 2.221
UA - Ucraina 1.951
BR - Brasile 1.298
HK - Hong Kong 1.178
VN - Vietnam 1.170
SE - Svezia 1.151
NL - Olanda 879
KR - Corea 876
FR - Francia 698
FI - Finlandia 661
TR - Turchia 518
DE - Germania 494
RU - Federazione Russa 409
GB - Regno Unito 403
IE - Irlanda 369
BG - Bulgaria 343
IN - India 288
CA - Canada 268
AR - Argentina 142
JP - Giappone 121
MA - Marocco 98
ID - Indonesia 79
MX - Messico 75
AU - Australia 74
BD - Bangladesh 71
CH - Svizzera 71
EC - Ecuador 70
IQ - Iraq 70
ES - Italia 64
PK - Pakistan 63
IR - Iran 62
ZA - Sudafrica 62
SN - Senegal 48
CO - Colombia 46
BE - Belgio 41
AT - Austria 40
EG - Egitto 39
CZ - Repubblica Ceca 35
CL - Cile 32
SA - Arabia Saudita 31
RO - Romania 30
TN - Tunisia 30
VE - Venezuela 27
IL - Israele 26
PT - Portogallo 25
AE - Emirati Arabi Uniti 24
DK - Danimarca 24
DZ - Algeria 24
PY - Paraguay 23
JO - Giordania 20
TW - Taiwan 20
UZ - Uzbekistan 19
PH - Filippine 17
KE - Kenya 16
MY - Malesia 16
UY - Uruguay 16
LT - Lituania 15
KZ - Kazakistan 14
PE - Perù 14
RS - Serbia 14
GR - Grecia 13
LB - Libano 13
SI - Slovenia 13
TH - Thailandia 13
HU - Ungheria 12
NO - Norvegia 12
SK - Slovacchia (Repubblica Slovacca) 12
CR - Costa Rica 11
EU - Europa 11
PS - Palestinian Territory 11
NZ - Nuova Zelanda 10
BO - Bolivia 9
BY - Bielorussia 9
NG - Nigeria 9
OM - Oman 9
AL - Albania 8
AZ - Azerbaigian 8
GE - Georgia 8
HR - Croazia 8
JM - Giamaica 8
LV - Lettonia 6
PA - Panama 6
TT - Trinidad e Tobago 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
MD - Moldavia 5
NP - Nepal 5
DO - Repubblica Dominicana 4
EE - Estonia 4
HN - Honduras 4
LU - Lussemburgo 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
BS - Bahamas 3
CY - Cipro 3
GT - Guatemala 3
Totale 58.134
Città #
Warsaw 3.452
Woodbridge 2.806
Singapore 2.287
Ann Arbor 2.150
Houston 2.081
Fairfield 1.729
Jacksonville 1.642
Ashburn 1.558
Chandler 1.141
Hong Kong 1.135
Wilmington 1.054
Seoul 846
San Jose 763
Seattle 734
Hefei 661
Princeton 635
Cambridge 595
Milan 585
Chicago 542
Beijing 501
Boardman 499
Rome 491
Trieste 384
Izmir 366
Ho Chi Minh City 354
Dublin 349
Columbus 336
Sofia 336
Zgierz 305
Lauterbourg 290
Los Angeles 263
Hanoi 238
Moscow 233
The Dalles 186
Toronto 177
Buffalo 175
Santa Clara 150
Dallas 145
Naples 136
Dearborn 126
San Diego 120
Redwood City 111
São Paulo 109
Verona 107
Bologna 106
Düsseldorf 105
Helsinki 99
New York 96
London 95
Council Bluffs 87
Florence 85
Frankfurt am Main 82
Turin 79
Bari 77
Palermo 76
Casablanca 75
Salt Lake City 71
Dong Ket 64
Genoa 57
Orem 55
Amsterdam 52
Guangzhou 52
Phoenix 52
Tokyo 52
Haiphong 50
Catania 48
Da Nang 48
Dakar 48
Brescia 47
Hamburg 46
Shanghai 45
Redmond 44
Padova 43
Nanjing 41
Rio de Janeiro 40
Cagliari 38
Munich 38
Washington 38
Falls Church 37
Venezia 37
Nuremberg 36
Torino 36
Kunming 33
Elk Grove Village 32
Norwalk 32
Tianjin 32
Chennai 30
Redondo Beach 30
Sacile 30
Brussels 29
Johannesburg 29
Modena 29
Brooklyn 28
Curitiba 28
Montreal 28
Ankara 27
Belo Horizonte 27
Mestre 27
Mumbai 27
Parma 27
Totale 35.685
Nome #
Danni cerebrali post-attinici 8.629
Valutazione neuropsicologica di quattro casi di encefalopatia post-attinica. 671
Bilirubin and inflammation in neurodegenerative and other neurological diseases 627
Focus on Neuro Behcet's disease: a review 608
An iatrogenic model of brain small-vessel disease: Post-radiation encephalopathy 532
Wernicke Korsakoff Encephalopathy 502
Brain Cytochrome p450 enzymes: a possible Therapeutic Targets for Neurological Diseases 449
Speech disorder and behavioral involvement in a thalamic stroke: a case report 437
Subcortical vascular damages for post radiation brain radiotherapy 434
The controversial role of homocysteine in neurology: From labs to clinical practice 410
Basal ganglia: Their role in complex cognitive procedures in experimental models and in clinical practice 405
Complex neurological symptoms in bilateral thalamic stroke due to Percheron artery occlusion 402
Hepatitis C-related cryoglobulinemic neuropathy: Potential role of oxcarbazepine for pain control 380
What does Doppler Ultrasonography Brings to the Diagnosis of Traumatic Vertebral Artery Dissection 372
Cortical modulation of pupillary function: Systematic review 343
Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease 336
Earliest mechanisms of dopaminergic neurons sufferance in a novel slow progressing ex vivo model of parkinson disease in rat organotypic cultures of substantia nigra 323
null 319
null 312
Management of restless legs syndrome in chronic liver disease: a challenge for the correct diagnosis and therapy 289
Anatomy of Basal Ganglia and Thalamus 287
Thiamine and alcohol for brain pathology: super-imposing or different causative factors for brain damage? 280
Small vessel disease to subcortical dementia: A dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit 269
null 266
The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases 266
Vitamin D in neurological disease: a rationale for a pathogenic impact 259
Akinetic-rigid and tremor-dominant parkinson's disease: Two distinct cognitive and behavioral evolutions 259
Apathy in corticobasal degeneration: possible parietal involvement 253
B vitamins and fatty acids: What do they share with small vessel disease-related dementia? 252
Thalamus and language: What do we know from vascular and degenerative pathologies 242
Cerebral hemodynamic changes during motor imagery and passive robot-assisted movement of the lower limbs 239
Non-alcoholic fatty liver disease and neurological defects 239
Olfactory loss in Multiple Sclerosis 238
From brain to heart: Possible role of amyloid-β in ischemic heart disease and ischemia-reperfusion injury 237
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 236
Homocysteine in neurology: From endothelium to Neurodegeneration 234
Bilingual aphasia and subcortical-cortical lesions. 231
Depressione vascolare e demenza vascolare sottocorticale. 228
A 12 MONTH FOLLOW-UP IN FIFTEEN PATIENTS WITH PARKINSON’ DISEASE: NEUROPSYCHOLOGICAL CHANGES AFTER SUBTHALAMIC NUCLEUS STIMULATION. 222
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 221
Sexual dysfunction in multiple sderosis: a case-control study. 1. Frequency and comparison of groups 217
Depression and Alzheimer's disease: Symptom or comorbidity? 217
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis 215
An f-MRI evaluation of cerebrocortical activation during learned motor performance. 214
Freezing in on: significato funzionale di un sintomo o di una sindrome. 212
Visual impairments and attention in parkinson's disease 199
Agraphia in early stage of Alzheimer’s Disease: , a correlation analysis with cognitive performances. 195
An Open-Label Pilot Study Comparing Rivastigmine and Low-Dose Aspirin for the Treatment of Symptoms Specific to Patients with Subcortical Vascular Dementia 194
A brainstem angioma: consideration on a single case. 194
Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms 192
Writing errors by normal subjects. 190
Small vessel disease-related dementia: An invalid neurovascular coupling? 190
Is Parkinson's disease an unique clinical entity? Rigid or tremor dominant PD: Two faces of the same coin 185
Vitamin D in the Brain Small Vessel Disease 183
BEHAVIORAL ALTERATIONS AND VASCULAR DEMENTIA 181
Apathy: A Complex Symptom Specific to the Clinical Pattern of Presentation of Parkinson’s Disease? 181
Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients 180
Ten-point clock test: a correlation analysis with other neuropsychological tests in dementia 180
Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality 178
A Comparison with writing alteration in AD. 177
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease 177
Ten-Point Clock Test: a correlation analysis with mini-mental state and proverb interpretation score in Alzheimer's disease 176
Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: A 24-month follow-up of 68 patients 176
Gabapentin for the Treatment of Behavioural Alterations in Dementia 174
Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation. 174
Rivastigmine and Parkinson dementia complex. 173
A NEUROPSYCHOLOGICAL COMPARISON BETWEEN SUBCORTICAL VASCULAR DEMENTIA AND FRONTAL LOBE DEMENTIA. 173
Deep brain stimulation of the subthalamus: Neuropsychological effects 173
A reduction of freezing of thoughts and of interference mistakes as a consequence of DBS-STN. 172
ACUTE ISCHEMIC STROKE MANAGEMENT: THE STATE OF THE ART HOT TOPICS IN NEUROLOGY AND PSYCHIATRY, ISSUE 6 171
Sexual dysfunction in Multiple Sclerosis. A case control study. Frequency and comparison of groups 171
Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients 171
Gabapentin treatment of glossopharyngeal neuralgia: a follow-up of four years of a single case 168
Apathy as a Key Symptom in Behavior Disorders: Difference Between Alzheimer’s Disease and Subcortical Vascular Dementia 168
Subcortical vascular dementia 167
Gait and Apathy as Relevant Symptoms of Subcortical Vascular Dementia 167
ALZHEIMER’S DEMENTIA AND VASCULAR RISK FACTORS. 165
Cortical-basal ganglionic degeneration: a clinical, functional and cognitive evaluation (1-year follow-up) 165
Risk factors for vascular dementia: hypotension as a key point. 164
An open, 16-month, comparative study on rivastigmine in subcortical vascular dementia 164
NEUROPSYCHOLOGICAL EVALUATION OF LATE ONSET POST-RADIOTHERAPY ENCEPHALOPATHY: A COMPARISON WITH VASCULAR DEMENTIA. 163
Corticobasal degeneration: Structural and functional MRI and single-photon emission computed tomography 161
An f-MRI evaluation of motor skills in corticobasal degeneration 161
Treatment of chronic hiccups: new perspectives 161
null 159
Dementia evaluation tests at the patient’s bedside: A neurological-internal approach. 159
Peculiar Aspects of Reading and Writing Performances in Patients with Olivopontocerebellar Atrophy 158
Different responses to rivastigmine in Subcortical vascular dementia and multi- infarct dementia 157
Alzeheimer or something else? Corticobasal degeneration presenting as dementia-phenotype 157
Alzheimer or Something Else? Corticobasal Degeneration Presenting as Dementia Phenotpye 157
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. II. CORRELATION ANALYSIS 156
A neuropsychological evaluation of freezing in on 155
eFFETTO DELLA DOXAZOSINA SUI FATTORI DI RISCHIO CARDIOVASCOLARE E SULLA FUNZIONE NERVOSA PERIFERICA IN PAZIENTI IPERTESI E DIABETICI: FOLLOW-UP A 12 MESI. 155
Fronto-temporal dementia versus Alzheimer disease 155
Behavioral disorders in dementia. Gabapentin as an atypical treatment: a- 20-month, not randomised controlled follow-up. 154
Memantine: reality and potentiality. 154
Cognitive changes following subthalamic nucleus stimulation in two Patients with Parkinson disease. 154
Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up 154
Alterazioni cognitive e funzionali nel follow-up di Pazienti con degenerazione corticobasale 152
null 152
Totale 32.155
Categoria #
all - tutte 148.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.136 0 0 0 0 0 0 0 0 0 551 163 422
2021/20223.761 142 318 364 367 90 197 126 195 499 478 285 700
2022/20235.424 552 505 355 544 557 894 132 409 598 182 426 270
2023/20244.170 253 294 314 283 383 371 494 717 58 211 371 421
2024/20258.181 493 418 598 803 760 703 591 614 1.083 774 587 757
2025/202613.847 1.613 829 1.389 1.763 1.174 1.461 1.789 638 1.540 1.651 0 0
Totale 58.928